| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2082345 | Drug Discovery Today: Disease Models | 2006 | 7 Pages |
Abstract
Animal models can provide considerable benefit for investigating the pathogenesis of the complex process of fibrosis in the lung. Systems include intratracheal administration of various chemical profibrotic agents such as bleomycin, gene overexpression or irradiation to mimic human pulmonary fibrosis; however, concerns regarding the direct transferability of findings to clinical disease exist. This review highlights advantages and deficiencies of different animal models of fibrosis and discusses their role in finding new treatment options for IPF-patients.
Section editor:Nelly Frossard – Université Louis Pasteur, Strasbourg, France
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Antje Moeller, Juan Carlos Rodriguez-Lecompte, Lingqiao Wang, Jack Gauldie, Martin Kolb,